Oak Thistle LLC Buys 2,568 Shares of Mettler-Toledo International, Inc. (NYSE:MTD)

Oak Thistle LLC increased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 357.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,287 shares of the medical instruments supplier's stock after buying an additional 2,568 shares during the period. Mettler-Toledo International accounts for 0.8% of Oak Thistle LLC's holdings, making the stock its 16th biggest holding. Oak Thistle LLC's holdings in Mettler-Toledo International were worth $3,882,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Greenleaf Trust raised its stake in Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after buying an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after buying an additional 11 shares during the last quarter. Albion Financial Group UT raised its stake in Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after buying an additional 11 shares during the last quarter. TD Private Client Wealth LLC raised its stake in Mettler-Toledo International by 5.4% during the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after buying an additional 11 shares during the last quarter. Finally, Congress Asset Management Co. raised its stake in Mettler-Toledo International by 1.8% during the first quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock worth $788,000 after buying an additional 12 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Insiders Place Their Bets

In related news, Director Michael A. Kelly sold 1,062 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the transaction, the director directly owned 120 shares in the company, valued at approximately $139,191.60. The trade was a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.94% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Barclays assumed coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and decreased their price target for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Bank of America lifted their price target on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Wall Street Zen downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $1,280.90.

Mettler-Toledo International Price Performance

Shares of NYSE MTD traded up $3.22 during mid-day trading on Friday, reaching $1,263.97. 155,612 shares of the company's stock traded hands, compared to its average volume of 136,780. The stock has a market cap of $26.27 billion, a P/E ratio of 31.52, a PEG ratio of 3.88 and a beta of 1.37. The business has a 50-day simple moving average of $1,183.68 and a 200 day simple moving average of $1,194.00. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, topping the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.17% and a negative return on equity of 556.22%. The business had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. During the same period in the previous year, the company earned $8.89 earnings per share. The firm's revenue for the quarter was down 4.6% compared to the same quarter last year. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.